Positive Phase 3 Trial in hATTR Amyloidosis With Polyneuropathy ...Middle East

Medscape - News
The RNAi therapeutic vutrisiran met its primary and secondary endpoints in the HELIOS-A phase 3 study of patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Phase 3 Trial in hATTR Amyloidosis With Polyneuropathy )

Apple Storegoogle play

Also on site :